Replies to post #8986 on Mast Therapeutics, Inc. (MSTX)

[leoncio1]

>News< Q2 financials.. Anx

SAN DIEGO, Aug. 8, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the periods ended June 30, 2011.

"As we head into the second half of the year, we are taking steps to prepare for our launch of Exelbine™ into the U.S. market, should it be approved on or around FDA's PDUFA goal date of September 1, 2011," said Brian M. Culley, Chief Executive Officer of ADVENTRX. "Having a commercial infrastructure will expand our strategic options and increase stockholder value."

Balance Sheet Highlights
As of June 30, 2011, the Company had cash totaling $42.0 million. Stockholders' equity amounted to $46.4 million as of June 30, 2011.

More:

http://finance.yahoo.com/news/ADVENTRX-Reports-Second-prnews-1300038977.html?x=0&.v=1

Looks solid,. :-) Good luck,.